Cargando…

Efficacy and Safety of Keverprazan Compared With Lansoprazole in the Treatment of Duodenal Ulcer: A Phase III, Randomized, Double-Blind, Multicenter Trial

Keverprazan is a novel potassium-competitive acid blocker for the treatment of acid-related disorders requiring potent acid inhibition. This study aimed to establish the noninferiority of keverprazan to lansoprazole in the treatment of patients with duodenal ulcer (DU). METHODS: In this phase III, d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Nian-di, Miao, Xin-pu, Liao, Ai-jun, Liu, Cheng-xia, Wu, Hao, Chen, Hong-hui, Li, Fang-fang, Guo, Qing-hong, Li, Sheng-bao, Tang, Yan-ping, Xia, Min, Liu, You-li, Li, Xing, Chen, Hui-xin, Liu, Xiao-wei, Zhang, Yan, Zhang, Zhen-yu, Chen, Min-hu, Xiao, Ying-lian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371330/ https://www.ncbi.nlm.nih.gov/pubmed/37235793 http://dx.doi.org/10.14309/ctg.0000000000000602

Ejemplares similares

A Multicenter, Randomized, Controlled Trial of Rebamipide Plus Lansoprazole for the Treatment of Postendoscopic Submucosal Dissection Ulcers
por: Yan, Bin, et al.
Publicado: (2019)

Risk factors for intestinal metaplasia in concomitant gastric and duodenal ulcer disease
por: HONG, JUN-BO, et al.
Publicado: (2014)

Keverprazan, a novel potassium‐competitive acid blocker: Multiple oral doses safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects
por: Zhou, Sufeng, et al.
Publicado: (2023)

The Helicobacter pylori duodenal ulcer promoting gene, dupA in China
por: Zhang, Zhiyu, et al.
Publicado: (2008)

Enhanced recovery after surgery in congenital duodenal obstruction
por: Zhu, Li-Bo, et al.
Publicado: (2023)

Comparisons Between Bacterial Communities in Mucosa in Patients With Gastric Antrum Ulcer and a Duodenal Ulcer
por: Chen, Xia, et al.
Publicado: (2018)

Preventive and therapeutic significance of octreotide combined with lansoprazole on post-ERCP pancreatitis and its effect on serum amylase, inflammatory factors and immune function
por: Chen, Zhiliang, et al.
Publicado: (2021)

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
por: Sugano, Kentaro, et al.
Publicado: (2011)

Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers – results from two phase 3, non‐inferiority randomised controlled trials
por: Miwa, H., et al.
Publicado: (2016)

Pharmacodynamics and Pharmacokinetics of a New Type of Compound Lansoprazole Capsule in Gastric Ulcer Rats and Beagle Dogs: Importance of Adjusting Oxidative Stress and Inflammation
por: Wei, Binbin, et al.
Publicado: (2019)

Gastric ulcer patients are more susceptible to developing gastric cancer compared with concomitant gastric and duodenal ulcer patients
por: HONG, JUN-BO, et al.
Publicado: (2014)

Duodenal Ulcer
Publicado: (1910)

Duodenal Ulcer
Publicado: (1912)

Ulcerative Duodenitis
por: Nakase, Hiroshi, et al.
Publicado: (2021)

Duodenal Ulcer
Publicado: (1914)

Experience in diagnosis and treatment of duodenal ulcer perforation in children
por: Shen, Qiulong, et al.
Publicado: (2023)

Neutrophil-derived S100A8/A9 promotes apoptosis of intestinal epithelial cells in children with duodenal ulcers
por: Cheng, Rong, et al.
Publicado: (2023)

The Effects of Helicobacter pylori Infection on Gastric Microbiota in Children With Duodenal Ulcer
por: Zheng, Wei, et al.
Publicado: (2022)

Risk factors for distal migration of biliary plastic stents and related duodenal injury
por: Yuan, Xiang-lei, et al.
Publicado: (2019)

Immune and Inflammatory Responses in GERD and Lansoprazole
por: Isomoto, Hajime, et al.
Publicado: (2007)

Toxic epidermal necrolysis induced by lansoprazole()
por: Fracaroli, Tainá Scalfoni, et al.
Publicado: (2013)

Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: A randomized, open-labeled, two-way crossover study
por: Zhan, Xian-Bao, et al.
Publicado: (2012)

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
por: Sugano, Kentaro, et al.
Publicado: (2012)

A Case of Duodenal Anisakiasis with Duodenal Ulcer
por: Hwang, David, et al.
Publicado: (2012)

Duodenal Ulcer with Massive Gastrointestinal Hemorrhage as an Initial Manifestation in Multiple Myeloma with Extramedullary Disease: A Case Report
por: Chiu, Hao-Tse, et al.
Publicado: (2022)

Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations
por: Alai, Milind, et al.
Publicado: (2015)

Collagenous colitis with mucosal ulcerations in a patient without nonsteroidal anti-inflammatory drug or lansoprazole use
por: Berry, Andrew C., et al.
Publicado: (2015)

Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers
por: Takahashi, Kazuya, et al.
Publicado: (2016)

Overexpression of TiERF1 enhances resistance to sharp eyespot in transgenic wheat
por: Chen, Liang, et al.
Publicado: (2008)

Gastric and Duodenal Ulcer
por: Mojumder, Binoy Lall
Publicado: (1928)

The Treatment of Duodenal Ulcer
por: Wood, W. Quarry
Publicado: (1945)

Perforated Duodenal Ulcer
por: Struthers, J. W.
Publicado: (1912)

Multiple Duodenal Ulcers
Publicado: (1932)

Ulcer, Perforated Duodenal
por: Struthers, J. W.
Publicado: (1913)

Gastric and Duodenal Ulcer
Publicado: (1907)

Perforations in Duodenal Ulcer
por: McGuire, Edgar R.
Publicado: (1912)

Gastric and Duodenal Ulcers
por: King, Clarence
Publicado: (1890)

Lansoprazole promotes cisplatin‐induced acute kidney injury via enhancing tubular necroptosis
por: Ye, Lin, et al.
Publicado: (2021)

Increasing gastric juice pH level prior to anti-Helicobacter pylori therapy may be beneficial to the healing of duodenal ulcers
por: FAN, HONG-YUN, et al.
Publicado: (2013)

Efficacy of Proton Pump Inhibitors for Patients with Duodenal Ulcers: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials
por: Hu, Zhan-Hong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_80t2nufogalqut7jnl72o1vh88